The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomised, double-blind, placebo-controlled trial

European Journal of Integrative Medicine ◽

10.1016/j.eujim.2012.07.633 ◽

2012 ◽

Vol 4 ◽

pp. 69

Author(s):

Cheng Hui-Man ◽

Chiang Leih-Chin ◽

Jan Ya-Min ◽

Li Tsai-Chung ◽

Chen Guang-Wei

Keyword(s):

Atopic Dermatitis ◽

Controlled Trial ◽

Herbal Product ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

The Efficacy and Safety of a Chinese Herbal Product (Xiao-Feng-San) for the Treatment of Refractory Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial

10.1542/peds.2011-2107bbbb ◽

2011 ◽

Vol 128 (Supplement 3) ◽

pp. S140.1-S140

Author(s):

Joann H. Lin

Keyword(s):

Atopic Dermatitis ◽

Controlled Trial ◽

Herbal Product ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

The Efficacy and Safety of a Chinese Herbal Product (Xiao-Feng-San) for the Treatment of Refractory Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial

International Archives of Allergy and Immunology ◽

10.1159/000318861 ◽

2011 ◽

Vol 155 (2) ◽

pp. 141-148 ◽

Author(s):

Hui-Man Cheng ◽

Leih-Chin Chiang ◽

Ya-Min Jan ◽

Guang-Wei Chen ◽

Tsai-Chung Li

Keyword(s):

Atopic Dermatitis ◽

Controlled Trial ◽

Herbal Product ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of a Chinese herbal product (P07P) for the treatment of canine atopic dermatitis

Veterinary Dermatology ◽

10.1046/j.0959-4493.2001.00267.x ◽

2001 ◽

Vol 12 (5) ◽

pp. 265-274 ◽

Author(s):

Terry M. Nagle ◽

Sheila M. Torres ◽

Kim L. Horne ◽

Robert Grover ◽

Mike T. Stevens

Keyword(s):

Atopic Dermatitis ◽

Controlled Trial ◽

Herbal Product ◽

Efficacy And Safety ◽

Double Blind ◽

Canine Atopic Dermatitis ◽

Double Blind Placebo ◽

Download Full-text

Evaluation of the efficacy and safety of a Chinese herbal formula (RCM-106) for atopic dermatitis: study protocol for a randomised, double-blind, placebo-controlled trial in children

BMJ Open ◽

10.1136/bmjopen-2013-003906 ◽

2013 ◽

Vol 3 (12) ◽

pp. e003906 ◽

Author(s):

Hsiewe Ying Tan ◽

Anthony L Zhang ◽

Charlie C Xue ◽

Dacan Chen ◽

Cliff Da Costa ◽

...

Keyword(s):

Atopic Dermatitis ◽

Study Protocol ◽

Controlled Trial ◽

Herbal Formula ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Chinese Herbal Formula ◽

Download Full-text

A randomized double blind, placebo controlled trial of a Chinese herbal preparation (CH100) in chronic Hepatitis C

Gastroenterology ◽

10.1016/s0016-5085(01)81907-7 ◽

2001 ◽

Vol 120 (5) ◽

pp. A384-A384

Author(s):

L MOLLISON ◽

L TOTTEN ◽

C HOVELL ◽

K THAYNE ◽

C CONNELLY ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Herbal Preparation ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1088945.542078 ◽

2007 ◽

Author(s):

Jonathan Schapiro

Keyword(s):

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108987.566149 ◽

2008 ◽

Author(s):

Johann Gudjonsson

Keyword(s):

Monoclonal Antibody ◽

Controlled Trial ◽

Interleukin 12 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958672.793516776 ◽

2016 ◽

Author(s):

Robin Spiller

Keyword(s):

Irritable Bowel Syndrome ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718524881.793498396 ◽

2014 ◽

Author(s):

David Daikh

Keyword(s):

Ankylosing Spondylitis ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and Safety of a Monthly Buprenorphine Depot Injection for Opioid Use Disorder: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3228895 ◽

2018 ◽

Author(s):

Barbara R. Haight ◽

Susan M. Learned ◽

Celine M. Laffont ◽

Paul J. Fudala ◽

Yue Zhao ◽

...

Keyword(s):

Controlled Trial ◽

Opioid Use Disorder ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Depot Injection

Download Full-text